Funding Opportunities

• Trailblazer Award for New and Early Stage Investigators (R21 Clinical Trial Optional)
  (PAR-24-022)
  National Institute of Biomedical Imaging and Bioengineering
  National Institute on Aging
  National Eye Institute
  Application Receipt Date(s): Multiple dates, see announcement.
• Cooperative Centers on Human Immunology (U19 Clinical Trial Optional)
  (RFA-AI-22-069)
  National Institute of Allergy and Infectious Diseases
  Application Receipt Date(s): April 7, 2023
• NCI Cancer Screening Research Network: ACCrual, Enrollment, and Screening Sites (ACCESS) Hub (UG1 Clinical Trial Required)
  (RFA-CA-23-020)
  National Cancer Institute
  Application Receipt Date(s): February 28, 2023
• NCI Cancer Screening Research Network: Statistics and Data Management Center (UG1 Clinical Trial Required)
  (RFA-CA-23-021)
  National Cancer Institute
  Application Receipt Date(s): February 28, 2023
• NCI Cancer Screening Research Network: Coordinating and Communication Center (UG1 Clinical Trial Required)
  (RFA-CA-23-022)
  National Cancer Institute
  Application Receipt Date(s): February 28, 2023
• HEAL Initiative: Sleep Predictors of Opioid-Use Disorder Treatment Outcomes Program (R01 Clinical Trial Optional)
  (RFA-DA-23-059)
  National Institute on Drug Abuse
  National Institute on Alcohol Abuse and Alcoholism
  National Heart, Lung, and Blood Institute
  National Center for Complementary and Integrative Health
  Application Receipt Date(s): February 10, 2023
• HEAL Initiative - Sleep Predictors of Opioid-Use Disorder Treatment Outcomes Program: Leadership and Data Co-ordinating Center (U01 Clinical Trial Optional)
  (RFA-DA-23-060)
  National Institute on Drug Abuse
  National Institute on Alcohol Abuse and Alcoholism
  National Heart, Lung, and Blood Institute
  Application Receipt Date(s): February 10, 2023
• Exploratory studies to investigate mechanisms of HIV infection, replication, latency, and/or pathogenesis in the context of substance use disorders (R61/R33 - Clinical Trial Not Allowed)
  (RFA-DA-24-002)
  National Institute on Drug Abuse
  Application Receipt Date(s): March 23, 2023
• Chronic Kidney Disease in Children Central Biochemistry Laboratory (U24 Clinical Trial Not Allowed)
  (RFA-DK-23-002)
  National Institute of Diabetes and Digestive and Kidney Diseases
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Heart, Lung, and Blood Institute
  Application Receipt Date(s): January 12, 2023
• Interventions that Address Structural Racism to Reduce Kidney Health Disparities Research Coordinating Center (U24 - Clinical Trial Not Allowed)
  (RFA-DK-23-003)
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Institute of Nursing Research
  Office of Disease Prevention
  National Institute on Minority Health and Health Disparities
  Application Receipt Date(s): January 12, 2023
• Environmental Health Sciences Core Centers (EHSCC) (P30 Clinical Trial Optional)
  (RFA-ES-22-010)
  National Institute of Environmental Health Sciences
  Application Receipt Date(s): Multiple dates, see announcement.